ドイツのトップ乳癌化学療法医師と価格を比較。こちらで最適なマッチングを見つけてください
ご要望と予算に基づいて最適な医師を厳選いたします
医学的監修者 Fahad Mawlood
医学編集者・データサイエンティストトップ医師
3
ドイツ
レビュー
14000+
実際の患者より
トップ各国の乳癌化学療法価格を比較
国をタップしてトップ医師と価格を表示
個別化された治療計画を無料で取得し、最良のオプションを選択してください。コミットメント不要 · サービス料金なし
最初に表示：
Pfaffenbach教授は130本以上の論文を執筆しており、アカデミック病院ゾーリンゲンの消化器内科・腫瘍内科・内科部門を率いています。
フォックス・ヴィオラ博士は、BKZゾーリンゲン血液腫瘍科・緩和医療科の主任医師です。同クリニックは、認定された集学的腫瘍センターです。フォックス博士は、ドイツおよびヨーロッパにおける腫瘍性疾患の薬物療法の第一人者であり、15年以上の臨床経験を有しています。
同博士は、ドイツ腫瘍学・血液腫瘍学会（GDHO）、ドイツ医師会、およびアメリカがん研究学会に所属しています。また、分子生物学の研究にも従事しており、その研究成果はがん治療および分子診断の発展に貢献しています。
主な専門領域は、化学療法、免疫療法、分子標的療法、および放射線療法です。フォックス博士は、革新的な治療法と患者への細やかな配慮で知られています。その取り組みにより、高い治癒率を達成し、同僚からの高い評価を得ています。
Séverine Iborra医師は、ゾーリンゲンのベルギッシェス乳腺センターにおいてセノロジー／乳腺クリニックを主導し、乳癌診療を専門としています。
海外のクリニックを選ぶことはストレスフルです。800,000名以上の患者をサポートしたBookimedは、お客様の懸念を理解しています。信頼できる医師、最高の価格品質オプション、複雑なケースの解決策を見つける方法を知っています。すべての段階でお客様をご案内いたします。
ヤン・マツィイフスキー
医療コーディネーターチーム責任者
4300+件以上の患者の旅をガイド
Bookimedで3年
Germanyの1022名の患者が今月当社を通じて医師を見つけました
2分のクイズ
目標、予算、スケジュールをお聞かせください
人間のマッチング + AI
アルゴリズムがマッチングを見つけ、コーディネーターが適合性を確認します
オプション準備完了
価格、パッケージ、日程を比較。コーディネーターとチャット
選択肢に迷っていますか？
治療をガイド
医療訓練を受けた専属コーディネーター
| 順位 | 医師 | 経験 | 適合する方 | 特色 | クリニックと所在地 | 診察 |
|---|---|---|---|---|---|---|
| #1 | 34年の経験 | 乳癌化学療法 | 腫瘍学を専門とする診療科を統括し、豊富な研究実績を有する。130本以上の論文を執筆し、主要な欧州消化器病学会の会員である。 | ドイツ | から $250 | |
| #2 | 19年の経験 | 乳癌化学療法 | 婦人科腫瘍学の専門知識を持ち、専門乳腺外来を主宰している。乳癌の腫瘍学的診断および低侵襲治療において認定資格を有する。 | ドイツ | お問い合わせください |
Top oncologists for breast cancer chemotherapy in Germany include board-certified specialists at accredited cancer centers. These experts typically hold German Cancer Society certifications and participate in multidisciplinary tumor boards. Leading doctors like Dr. Viola Fox and Dr. Séverine Iborra integrate molecular diagnostics with personalized treatment protocols.
Bookimed Expert Insight: Data shows that choosing a dually qualified specialist often improves the patient journey. For example, Dr. Séverine Iborra in Solingen is a specialist in both gynecology and oncology. This combination allows one doctor to manage surgical diagnostics and chemotherapy protocols concurrently. Patients at these centers benefit from consolidated care without needing separate visits for imaging and treatment.
Patient Consensus: Patients emphasize that receiving a clear roadmap of the chemotherapy cycles and side-effect management is vital. Many found that large university hospitals offer the best coordination for pathology and imaging under one roof. They also noted that having English-speaking staff significantly reduces the stress of undergoing intensive treatment abroad.
Qualified breast cancer doctors in Germany must hold Facharzt certification in oncology or gynecology. You can verify their expertise by checking for associations with centers accredited by the German Cancer Society. Top specialists often lead multidisciplinary tumor boards to personalize chemotherapy protocols and manage complex cases.
Bookimed Expert Insight: German oncology structures prioritize interdisciplinary leadership. For example, Dr. Séverine Iborra at Solingen leads a specialized Senology center, while Prof. Boris Pfaffenbach heads an entire oncology department. This dual focus means your chemotherapy plan is overseen by a specialist who also manages the broader clinical department and participates in integrated tumor boards.
Patient Consensus: Patients note that well-qualified doctors often provide a written protocol immediately after the first consultation. They feel more confident when they see a multidisciplinary team, including surgeons and oncologists, collaborating on their specific case details. Many were relieved to find that reputable specialists encourage second opinions to confirm the best treatment path.
International patients can obtain independent second opinions from breast cancer specialists at leading German university hospitals. Board-certified oncologists provide these reviews through multidisciplinary tumor boards. They evaluate pathology reports and imaging to verify diagnoses. Remote consultations via video are frequently available for international cases.
Bookimed Expert Insight: Data shows that choosing specialists in academic centers like Bremen-Mitte or Solingen provides access to extensive research backgrounds. For instance, Prof. Boris Pfaffenbach has authored over 130 publications. This academic focus ensures patients receive opinions based on the latest clinical trials and innovative protocols. This is particularly valuable for rare or aggressive breast cancer subtypes.
Patient Consensus: Patients note that providing complete records is essential for a meaningful review. Many were relieved when specialists confirmed their current plans or refined treatment steps. They found that major clinics provide detailed written reports that are easy to share with local doctors.
German breast cancer specialists use both neoadjuvant and adjuvant chemotherapy based on individual tumor characteristics. Neoadjuvant therapy before surgery is favored for aggressive or large tumors to shrink them. This approach often allows for breast-conserving surgery instead of a full mastectomy.
Bookimed Expert Insight: German clinics like Academic Hospital Solingen and Nordwest Clinic utilize multidisciplinary boards to decide the chemotherapy sequence. Dr. Séverine Iborra at Solingen leads a dedicated breast clinic where molecular diagnostics guide these decisions. Data shows that German professors, such as Dr. Boris Pfaffenbach, often integrate extensive research into personalized protocols. This ensures the timing of chemotherapy aligns with the latest clinical findings for each specific cancer subtype.
Patient Consensus: Patients note that the treatment sequence feels like a collaborative decision between oncologists and surgeons. They appreciate that doctors explain how shrinking the tumor first can lead to less invasive surgery. Many felt reassured when their medical team adjusted the plan based on how the tumor responded to initial doses.
Breast cancer doctors in Germany use targeted therapies like HER2-inhibitors and CDK4/6 inhibitors alongside chemotherapy. Experts such as Dr. Viola Fox at Medical Center Solingen apply molecular diagnostics to select precise antibody-drug conjugates. This personalized approach often includes immunotherapy and specialized interventional radiology to improve outcomes.
Bookimed Expert Insight: German oncology centers stand out by staffing dual-qualified specialists. For instance, Dr. Viola Fox holds certifications in both oncology and genetics. This allows clinics to integrate molecular tumor boards directly into the treatment planning phase. Patients benefit from real-time genomic insights that determine if they qualify for the latest clinical trials.
Patient Consensus: Patients find that treatment plans are strictly driven by detailed pathology results like HER2 and BRCA status. Many note the frequency of neoadjuvant therapy, which combines targeted drugs with chemotherapy to shrink tumors before surgery. They emphasize feeling reassured by the highly protocolized nature of German cancer centers.